ATNM - Actinium Pharmaceuticals, Inc.
1.21
0.010 0.826%
Share volume: 32,397
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$1.20
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 04-26-2024 | 08-05-2024 | 11-14-2024 | 05-09-2025 | 08-08-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 88.352 M | 89.861 M | 82.114 M | 68.647 M | 63.017 M | 56.151 M | |
| Current Assets | 85.373 M | 87.068 M | 79.520 M | 66.456 M | 61.029 M | 54.366 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 84.057 M | 86.037 M | 78.660 M | 65.325 M | 59.928 M | 53.391 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 496.000 K | 460.000 K | 412.000 K | 317.000 K | 271.000 K | 226.000 K | |
| Other Assets | 2.483 M | 2.333 M | 2.182 M | 1.874 M | 1.717 M | 1.559 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 88.352 M | 89.861 M | 82.114 M | 68.647 M | 63.017 M | 56.151 M | |
| Total liabilities | 44.495 M | 46.026 M | 43.906 M | 42.953 M | 44.004 M | 42.367 M | |
| Total current liabilities | 8.064 M | 9.728 M | 7.755 M | 7.110 M | 8.314 M | 6.834 M | |
| Accounts Payable | 0.000 | 9.177 M | 7.195 M | 6.520 M | 7.714 M | 6.224 M | |
| Other liabilities | 1.414 M | 1.284 M | 1.139 M | 836.000 K | 685.000 K | 531.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 1.414 M | 1.284 M | 1.139 M | 836.000 K | 685.000 K | 531.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 43.857 M | 43.835 M | 38.208 M | 25.694 M | 19.013 M | 13.784 M | |
| Common stock | 390.110 M | 401.441 M | 407.382 M | 417.458 M | 417.655 M | 417.557 M | |
| Retained earnings | -346.253 M | -357.606 M | -369.174 M | -391.764 M | -398.642 M | -403.773 M |